EXPERIENCE A NEW LIFE
Autologous Micrografting Treatment: The first biocompatible solution that relieves pain
and restores joint health with a single session, using the patient’s own biological composition.
FAST
PAIN RELIEF
LONG-LASTING
RESULTS
NON INVASIVE
PROCEDURE
Why choose Mytocel MSK?
PAIN RELIEF
RESULTS
in just 1 session
PROCEDURE
REGENERATIVE
TECHNOLOGY
OF REJECTION
Would you like to speak with a professional?
What is the Mytocel MSK Treatment About?
Personalized Diagnosis
Treatment Application
Fast Results, Long-lasting Relief
Have you had many sessions of PRP or hyaluronic acid for joint pain without achieving the desired results?
Has joint pain forced you to give up your favorite sports?
Do you still feel full of energy, but your hips and knees say otherwise?
Have you stopped doing daily activities because of joint pain?
Diagnosed with osteoarthritis (Grade I to III) and finding it hard to enjoy life as you used to?
RIGENERA TECHNOLOGY
THE SCIENCE BEHIND
This revolutionary approach to pain management and promoting joint regeneration involves collecting a small tissue sample from the patient. The tissue is then mechanically disaggregated using our patented Rigenera® technology to create an injectable biocompatible solution of micro particles called micrografts, smaller than 80 microns. These micrografts contain essential biological components that activate the regeneration process.
The uniqueness of our treatment lies in the fact that it is both autologous (from the same patient) and homologous (same type of tissue) to treat the affected area. This makes it stand out in the market, harnessing the body’s natural healing capabilities to restore joint health.
The entire process takes just 30 minutes, is minimally invasive, and allows the patient to return to normal activities on the same day. Results begin to appear within 2 weeks and can last for more than 3 years.
Frequently asked questions
Mytocel MSK is a regenerative treatment that uses autologous micrografts (AMT) obtained through Rigenera® technology to treat joint pain and promote the natural healing of tissues.
Mytocel MSK employs patented Rigenera® technology, which mechanically disaggregates a sample of the patient’s tissue to create an injectable solution of autologous micrografts composed of progenitor cells, exosomes, and tissue-specific growth factors that promote natural tissue healing.
No, the procedure is outpatient and does not require hospitalization. Most patients can return to their normal activities the following day.
Most patients can resume sporting activities within 2 weeks, depending on their doctor’s recommendations and the progress of their recovery.
Patients typically experience significant pain relief and improved mobility from 2 weeks post-treatment.
The procedure is minimally invasive, and the extraction of tissue biopsies is performed with local anaesthesia to minimize any discomfort.
Use our contact form to redirect you to a certified medical center to perform the Mytocel MSK treatment.
PAIN FREE LIFE STORIES
KNEE INJURY
“My knees have felt amazing since Mytocel MSK in 2018. I have not needed any additional treatment.”
After serious knee injuries, Mytocel MSK provided long-lasting relief without the need for additional interventions.
“After one session, my left hand felt completely restored.”
Thanks to the Mytocel MSK treatment, I can now write, open doors, and manage everyday tasks again. The improvement in bothhands, especially my left, has
KNEE INJURY
“It was either surgery or a miracle, and luckily, I got the Mytocel MSK Treatment.”
After struggling with PRP treatments that didn’t work, I was able to run and train within a week of receiving Mytocel MSK.
CHRONIC ANKLE INJURY
“I couldn’t put any weight on my foot, and surgery was my only option—until Mytocel MSK.”
After 9 months of pain, Mytocel MSK allowed me to return to work, running, and even play volleyball without any pain.